Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Non-Steroidal Anti-Inflammatory Drugs
1.2.3 Steroidal Anti-Inflammatory Drugs
1.2.4 Slow Acting Drug
1.2.5 Immunological Preparation
1.3 Market by Application
1.3.1 Global Antirheumatics Pharmaceutical Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Industry
1.3.3 Hospital and Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antirheumatics Pharmaceutical Market Perspective (2018-2033)
2.2 Antirheumatics Pharmaceutical Growth Trends by Region
2.2.1 Global Antirheumatics Pharmaceutical Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Antirheumatics Pharmaceutical Historic Market Size by Region (2018-2023)
2.2.3 Antirheumatics Pharmaceutical Forecasted Market Size by Region (2024-2033)
2.3 Antirheumatics Pharmaceutical Market Dynamics
2.3.1 Antirheumatics Pharmaceutical Industry Trends
2.3.2 Antirheumatics Pharmaceutical Market Drivers
2.3.3 Antirheumatics Pharmaceutical Market Challenges
2.3.4 Antirheumatics Pharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antirheumatics Pharmaceutical Players by Revenue
3.1.1 Global Top Antirheumatics Pharmaceutical Players by Revenue (2018-2023)
3.1.2 Global Antirheumatics Pharmaceutical Revenue Market Share by Players (2018-2023)
3.2 Global Antirheumatics Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antirheumatics Pharmaceutical Revenue
3.4 Global Antirheumatics Pharmaceutical Market Concentration Ratio
3.4.1 Global Antirheumatics Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antirheumatics Pharmaceutical Revenue in 2022
3.5 Antirheumatics Pharmaceutical Key Players Head office and Area Served
3.6 Key Players Antirheumatics Pharmaceutical Product Solution and Service
3.7 Date of Enter into Antirheumatics Pharmaceutical Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antirheumatics Pharmaceutical Breakdown Data by Type
4.1 Global Antirheumatics Pharmaceutical Historic Market Size by Type (2018-2023)
4.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Type (2024-2033)
5 Antirheumatics Pharmaceutical Breakdown Data by Application
5.1 Global Antirheumatics Pharmaceutical Historic Market Size by Application (2018-2023)
5.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Antirheumatics Pharmaceutical Market Size (2018-2033)
6.2 North America Antirheumatics Pharmaceutical Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Antirheumatics Pharmaceutical Market Size by Country (2018-2023)
6.4 North America Antirheumatics Pharmaceutical Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antirheumatics Pharmaceutical Market Size (2018-2033)
7.2 Europe Antirheumatics Pharmaceutical Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Antirheumatics Pharmaceutical Market Size by Country (2018-2023)
7.4 Europe Antirheumatics Pharmaceutical Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antirheumatics Pharmaceutical Market Size (2018-2033)
8.2 Asia-Pacific Antirheumatics Pharmaceutical Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Region (2018-2023)
8.4 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antirheumatics Pharmaceutical Market Size (2018-2033)
9.2 Latin America Antirheumatics Pharmaceutical Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Antirheumatics Pharmaceutical Market Size by Country (2018-2023)
9.4 Latin America Antirheumatics Pharmaceutical Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antirheumatics Pharmaceutical Market Size (2018-2033)
10.2 Middle East & Africa Antirheumatics Pharmaceutical Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Country (2018-2023)
10.4 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Antirheumatics Pharmaceutical Introduction
11.1.4 AbbVie Revenue in Antirheumatics Pharmaceutical Business (2018-2023)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Antirheumatics Pharmaceutical Introduction
11.2.4 Amgen Revenue in Antirheumatics Pharmaceutical Business (2018-2023)
11.2.5 Amgen Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Antirheumatics Pharmaceutical Introduction
11.3.4 Pfizer Revenue in Antirheumatics Pharmaceutical Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Roche Holding AG
11.4.1 Roche Holding AG Company Detail
11.4.2 Roche Holding AG Business Overview
11.4.3 Roche Holding AG Antirheumatics Pharmaceutical Introduction
11.4.4 Roche Holding AG Revenue in Antirheumatics Pharmaceutical Business (2018-2023)
11.4.5 Roche Holding AG Recent Development
11.5 Novartis International AG
11.5.1 Novartis International AG Company Detail
11.5.2 Novartis International AG Business Overview
11.5.3 Novartis International AG Antirheumatics Pharmaceutical Introduction
11.5.4 Novartis International AG Revenue in Antirheumatics Pharmaceutical Business (2018-2023)
11.5.5 Novartis International AG Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Antirheumatics Pharmaceutical Introduction
11.6.4 Johnson & Johnson Revenue in Antirheumatics Pharmaceutical Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Antirheumatics Pharmaceutical Introduction
11.7.4 Bristol-Myers Squibb Revenue in Antirheumatics Pharmaceutical Business (2018-2023)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Antirheumatics Pharmaceutical Introduction
11.8.4 Merck Revenue in Antirheumatics Pharmaceutical Business (2018-2023)
11.8.5 Merck Recent Development
11.9 UCB S.A.
11.9.1 UCB S.A. Company Detail
11.9.2 UCB S.A. Business Overview
11.9.3 UCB S.A. Antirheumatics Pharmaceutical Introduction
11.9.4 UCB S.A. Revenue in Antirheumatics Pharmaceutical Business (2018-2023)
11.9.5 UCB S.A. Recent Development
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Company Detail
11.10.2 Eli Lilly and Company Business Overview
11.10.3 Eli Lilly and Company Antirheumatics Pharmaceutical Introduction
11.10.4 Eli Lilly and Company Revenue in Antirheumatics Pharmaceutical Business (2018-2023)
11.10.5 Eli Lilly and Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Non-Steroidal Anti-Inflammatory Drugs
Table 3. Key Players of Steroidal Anti-Inflammatory Drugs
Table 4. Key Players of Slow Acting Drug
Table 5. Key Players of Immunological Preparation
Table 6. Global Antirheumatics Pharmaceutical Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Antirheumatics Pharmaceutical Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Antirheumatics Pharmaceutical Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Antirheumatics Pharmaceutical Market Share by Region (2018-2023)
Table 10. Global Antirheumatics Pharmaceutical Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Antirheumatics Pharmaceutical Market Share by Region (2024-2033)
Table 12. Antirheumatics Pharmaceutical Market Trends
Table 13. Antirheumatics Pharmaceutical Market Drivers
Table 14. Antirheumatics Pharmaceutical Market Challenges
Table 15. Antirheumatics Pharmaceutical Market Restraints
Table 16. Global Antirheumatics Pharmaceutical Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Antirheumatics Pharmaceutical Market Share by Players (2018-2023)
Table 18. Global Top Antirheumatics Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antirheumatics Pharmaceutical as of 2022)
Table 19. Ranking of Global Top Antirheumatics Pharmaceutical Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Antirheumatics Pharmaceutical Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Antirheumatics Pharmaceutical Product Solution and Service
Table 23. Date of Enter into Antirheumatics Pharmaceutical Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antirheumatics Pharmaceutical Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Antirheumatics Pharmaceutical Revenue Market Share by Type (2018-2023)
Table 27. Global Antirheumatics Pharmaceutical Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Antirheumatics Pharmaceutical Revenue Market Share by Type (2024-2033)
Table 29. Global Antirheumatics Pharmaceutical Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Antirheumatics Pharmaceutical Revenue Market Share by Application (2018-2023)
Table 31. Global Antirheumatics Pharmaceutical Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Antirheumatics Pharmaceutical Revenue Market Share by Application (2024-2033)
Table 33. North America Antirheumatics Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Antirheumatics Pharmaceutical Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Antirheumatics Pharmaceutical Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Antirheumatics Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Antirheumatics Pharmaceutical Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Antirheumatics Pharmaceutical Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Antirheumatics Pharmaceutical Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Antirheumatics Pharmaceutical Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Antirheumatics Pharmaceutical Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Antirheumatics Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Antirheumatics Pharmaceutical Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Antirheumatics Pharmaceutical Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Antirheumatics Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Antirheumatics Pharmaceutical Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Antirheumatics Pharmaceutical Market Size by Country (2024-2033) & (US$ Million)
Table 48. AbbVie Company Detail
Table 49. AbbVie Business Overview
Table 50. AbbVie Antirheumatics Pharmaceutical Product
Table 51. AbbVie Revenue in Antirheumatics Pharmaceutical Business (2018-2023) & (US$ Million)
Table 52. AbbVie Recent Development
Table 53. Amgen Company Detail
Table 54. Amgen Business Overview
Table 55. Amgen Antirheumatics Pharmaceutical Product
Table 56. Amgen Revenue in Antirheumatics Pharmaceutical Business (2018-2023) & (US$ Million)
Table 57. Amgen Recent Development
Table 58. Pfizer Company Detail
Table 59. Pfizer Business Overview
Table 60. Pfizer Antirheumatics Pharmaceutical Product
Table 61. Pfizer Revenue in Antirheumatics Pharmaceutical Business (2018-2023) & (US$ Million)
Table 62. Pfizer Recent Development
Table 63. Roche Holding AG Company Detail
Table 64. Roche Holding AG Business Overview
Table 65. Roche Holding AG Antirheumatics Pharmaceutical Product
Table 66. Roche Holding AG Revenue in Antirheumatics Pharmaceutical Business (2018-2023) & (US$ Million)
Table 67. Roche Holding AG Recent Development
Table 68. Novartis International AG Company Detail
Table 69. Novartis International AG Business Overview
Table 70. Novartis International AG Antirheumatics Pharmaceutical Product
Table 71. Novartis International AG Revenue in Antirheumatics Pharmaceutical Business (2018-2023) & (US$ Million)
Table 72. Novartis International AG Recent Development
Table 73. Johnson & Johnson Company Detail
Table 74. Johnson & Johnson Business Overview
Table 75. Johnson & Johnson Antirheumatics Pharmaceutical Product
Table 76. Johnson & Johnson Revenue in Antirheumatics Pharmaceutical Business (2018-2023) & (US$ Million)
Table 77. Johnson & Johnson Recent Development
Table 78. Bristol-Myers Squibb Company Detail
Table 79. Bristol-Myers Squibb Business Overview
Table 80. Bristol-Myers Squibb Antirheumatics Pharmaceutical Product
Table 81. Bristol-Myers Squibb Revenue in Antirheumatics Pharmaceutical Business (2018-2023) & (US$ Million)
Table 82. Bristol-Myers Squibb Recent Development
Table 83. Merck Company Detail
Table 84. Merck Business Overview
Table 85. Merck Antirheumatics Pharmaceutical Product
Table 86. Merck Revenue in Antirheumatics Pharmaceutical Business (2018-2023) & (US$ Million)
Table 87. Merck Recent Development
Table 88. UCB S.A. Company Detail
Table 89. UCB S.A. Business Overview
Table 90. UCB S.A. Antirheumatics Pharmaceutical Product
Table 91. UCB S.A. Revenue in Antirheumatics Pharmaceutical Business (2018-2023) & (US$ Million)
Table 92. UCB S.A. Recent Development
Table 93. Eli Lilly and Company Company Detail
Table 94. Eli Lilly and Company Business Overview
Table 95. Eli Lilly and Company Antirheumatics Pharmaceutical Product
Table 96. Eli Lilly and Company Revenue in Antirheumatics Pharmaceutical Business (2018-2023) & (US$ Million)
Table 97. Eli Lilly and Company Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antirheumatics Pharmaceutical Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Antirheumatics Pharmaceutical Market Share by Type: 2022 VS 2033
Figure 3. Non-Steroidal Anti-Inflammatory Drugs Features
Figure 4. Steroidal Anti-Inflammatory Drugs Features
Figure 5. Slow Acting Drug Features
Figure 6. Immunological Preparation Features
Figure 7. Global Antirheumatics Pharmaceutical Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Antirheumatics Pharmaceutical Market Share by Application: 2022 VS 2033
Figure 9. Pharmaceutical Industry Case Studies
Figure 10. Hospital and Clinic Case Studies
Figure 11. Other Case Studies
Figure 12. Antirheumatics Pharmaceutical Report Years Considered
Figure 13. Global Antirheumatics Pharmaceutical Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Antirheumatics Pharmaceutical Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Antirheumatics Pharmaceutical Market Share by Region: 2022 VS 2033
Figure 16. Global Antirheumatics Pharmaceutical Market Share by Players in 2022
Figure 17. Global Top Antirheumatics Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antirheumatics Pharmaceutical as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Antirheumatics Pharmaceutical Revenue in 2022
Figure 19. North America Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Antirheumatics Pharmaceutical Market Share by Country (2018-2033)
Figure 21. United States Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Antirheumatics Pharmaceutical Market Share by Country (2018-2033)
Figure 25. Germany Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Antirheumatics Pharmaceutical Market Share by Region (2018-2033)
Figure 33. China Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Antirheumatics Pharmaceutical Market Share by Country (2018-2033)
Figure 41. Mexico Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Antirheumatics Pharmaceutical Market Share by Country (2018-2033)
Figure 45. Turkey Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Antirheumatics Pharmaceutical Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. AbbVie Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2018-2023)
Figure 48. Amgen Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2018-2023)
Figure 50. Roche Holding AG Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2018-2023)
Figure 51. Novartis International AG Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2018-2023)
Figure 52. Johnson & Johnson Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2018-2023)
Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2018-2023)
Figure 54. Merck Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2018-2023)
Figure 55. UCB S.A. Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2018-2023)
Figure 56. Eli Lilly and Company Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed